Search Within

Stephanie Michelle Downs-Canner

Formats
  1. Journal Article (17)
  2. Meeting Abstract (11)
  3. Miscellaneous (8)
  4. Review (4)
  5. Editorial (3)
  6. Correspondence (1)
Groups
  1. Surgery (44)
  2. Epidemiology and Biostatistics (14)
  3. Principal Biostatisticians (9)
  4. Graduate Medical Education (8)
  5. Survivorship Research (8)
  6. Biostatistics Service (5)

More Groups

People
  1. Monica Morrow (17)
  2. George Plitas (10)
  3. Nour Abuhadra (10)
  4. Srinivasa Sevilimedu Veeravalli (9)
  5. Giacomo Montagna (6)
  6. Natalia Polidorio Machado (6)

More People

Years
  1. 2025 (11)
  2. 2024 (9)
  3. 2023 (11)
  4. 2022 (6)
  5. 2020 (1)
  6. 2019 (5)

More Years

Publications
  1. Annals of Surgical Oncology (27)
  2. Journal of Clinical Oncology (3)
  3. Annals of Surgery (2)
  4. Advances in Immunology (1)
  5. American Journal of Surgery (1)
  6. Cancer (1)

More Publications

Publishers
  1. Springer (27)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (3)
  4. Lippincott Williams & Wilkins (2)
  5. Nature Publishing Group (2)
  6. Wiley Blackwell (2)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Analysis of specimen mammography with artificial intelligence to predict margin status
    Miscellaneous

    Chen, K. A.; Kirchoff, K. E.; Butler, L. R.; Holloway, A. D.; Kapadia, M. R.; Kuzmiak, C. M.; Downs-Canner, S. M.; Spanheimer, P. M.; Gallagher, K. K.; Gomez, S. M.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Analysis of specimen mammography with artificial intelligence to predict margin status
    Journal Article

    Chen, K. A.; Kirchoff, K. E.; Butler, L. R.; Holloway, A. D.; Kapadia, M. R.; Kuzmiak, C. M.; Downs-Canner, S. M.; Spanheimer, P. M.; Gallagher, K. K.; Gomez, S. M.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Selecting triple negative breast cancer patients for immunotherapy
    Review

    Downs-Canner, S.; Mittendorf, E. A.
    Surgical Oncology Clinics of North America (2023)

    Fulltext@MSK | Save
  • Prospective evaluation of pathologic response with neoadjuvant chemo-immunotherapy in metaplastic breast cancer
    Meeting Abstract

    Abuhadra, N.; Chen, Y.; Plitas, G.; Razavi, P.; Pareja, F.; Reis-Filho, J. S.; Wen, H. Y.; Khan, A. J.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Impact of neoadjuvant chemo-immunotherapy on surgical outcomes and time to radiation in triple negative breast cancer
    Meeting Abstract

    Myers, S. P.; Veeravalli, S. S.; Jones, V. M.; Abuhadra, N.; Montagna, G.; Plitas, G.; Morrow, M.; Downs-Canner, S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Preoperative immunotherapy combined with chemotherapy for triple-negative breast cancer: Perspective on the KEYNOTE-522 study
    Editorial

    Downs-Canner, S.; Mittendorf, E. A.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of a pilot virtual mentorship program for medical students interested in surgery
    Journal Article

    Jadi, J.; Shaughnessy, E.; Barry, L.; Reyna, C.; Tsai, S.; Downs-Canner, S. M.; Myers, S.
    American Journal of Surgery (2023)

    Fulltext@MSK | Save
  • Can we forgo sentinel lymph node biopsy in women aged ≥ 50 years with early-stage hormone-receptor-positive HER2-negative special histologic subtype breast cancer?
    Journal Article

    Knape, N.; Park, J. H.; Agala, C. B.; Spanheimer, P.; Morrow, M.; Downs-Canner, S.; Baldwin, X. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Author Reflections: Using population-level data to individualize surgical decision-making and reduce morbidity
    Editorial

    Knape, N.; Downs-Canner, S.; Baldwin, X. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Can we forego sentinel lymph node biopsy in women ≥50 years of age with early-stage hormone receptor-positive HER2-negative special histologic subtype breast cancer?
    Miscellaneous

    Knape, N.; Park, J. H.; Agala, C. B.; Spanheimer, P.; Morrow, M.; Downs-Canner, S.; Baldwin, X. L.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save